Background: Continuous rise of type 2 diabetes mellitus (T2DM) global prevalence, has led to a subsequent increase in the prevalence of diabetic kidney disease (DKD). DKD is associated with higher levels of inflammation and impaired kidney function. Many patients do not receive adequate treatment for this condition. This research aims to evaluate the therapeutic impact of autologous dendritic cell transfer by examining its effects on renal microstructural changes as assessed through Diffusion Tensor Imaging (DTI) MRI, alongside the analysis of key inflammatory biomarkers, namely Matrix Metalloproteinase-9 (MMP-9) and Intercellular Adhesion Molecule-1 (ICAM-1). Methods: A clinical trial with an open-label design was performed with 25 DKD patients receiving outpatient care at Gatot Soebroto Army Hospital. Each participant was administered a single injection of autologous dendritic cells. Evaluations were conducted both prior to and one month following the treatment. The primary measurements included Diffusion Tensor Imaging (DTI) MRI-derived Fractional Anisotropy (FA) scans and the inflammatory biomarker MMP-9. Results: A notable increase in FA was observed, rising from 242.57 ± 63.97 at baseline to 305.61 ± 152.32 one month after the dendritic cell injection. However, there were no significant changes in MMP-9 and ICAM-1 levels. Additionally, a negative correlation was found between FA and MMP-9 (r = −0.324, p = 0.025). Conclusion: The transfer of autologous dendritic cells significantly enhanced FA, which correlates with a reduction in the inflammatory biomarker MMP-9, suggesting a potential impact on renal repair in DKD.
Background: The incidence of type 2 diabetes mellitus (T2DM) is increasing worldwide, leading to a higher incidence of diabetic kidney disease (DKD). DKD has increased inflammation and decreased kidney function. Patients have not received op-timal therapy. This study aims to see the effect of autologous dendritic cell administra-tion on DTI MRI examination and biomarkers of Matrix Metalloproteinase-9 (MMP-9) and Intercellular Adhesion Molecule-1 (ICAM-1). Methods: An open-label clinical trial study was conducted on 25 DKD outpatients at Gatot Soebroto Army Hospital. Each subject received a one-time injection of Autologous Dendritic Cells, with evaluation conducted before and 1 month after administration. Parameters measured included Fractional Anisotropy (FA) using Diffuse Tensor Imaging in MRI sequences and in-flammatory biomarker MMP-9. Results: A significant increase shown in Fractional An-isotropy from 242.57 ± 63.97 at baseline to 305.61 ± 152.32 one month after DC injection, while MMP-9 and ICAM-1 showed no significant change. There was a negative corre-lation between FA and MMP-9 values (r = -0.324, p = 0.025). Conclusion: Autologous dendritic cell administration can significantly improve FA, which is associated with a decrease in the inflammatory biomarker MMP-9 and affects renal repair in DKD